Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Tilleke & GibbinsSukontip Jitmongkolthong and Saithong Rattana of Tilleke & Gibbins describe how Laos has improved its framework to enforce IP rights through border measures -
Sponsored by Purplevine IPXiaoyan Zhou of Purplevine IP explains how to protect IP in the rapidly developing area of AI medical devices in China, and the risks involved
-
Sponsored by FB RiceDavid Herman of FB Rice explains what steps are involved in interpreting New Zealand’s Patents Act 2013 and summarises several significant rulings that have established precedents in patent law
-
Sponsored by Saint Island International Patent & Law OfficesSumin Lai of Saint Island International Patent & Law examines the IP and Commercial Court v ordinary courts to exercise jurisdiction over civil actions from IP rights in Taiwan
-
Sponsored by Bird & BirdRoman Brtka of Bird & Bird comments on the Ferrari Front Kit case and explains the practical consequences for manufacturers that want to protect a part of a product independently of the whole product
-
Sponsored by Purplevine IPJoin Ude Lu, the chief IP counsel (US) of Purplevine IP, Helen Zhang, the litigation manager of Purplevine IP in Beijing, and Penny Sun, the brand protection manager of ABRO Industry, as they discuss evidence collection for patent enforcement in China and the US virtually with Managing IP on November 9 at 10am (US ET) / 3pm (UK) / 11pm (China)
